Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Letter to the Editor

Why 25-dehydroxyvitamin D is a negative acute-phase reactant

Maria J. Antonelli, MD, Irving Kushner, MD and Murray Epstein, MD, FASN, FACP
Cleveland Clinic Journal of Medicine September 2023, 90 (9) 535; DOI: https://doi.org/10.3949/ccjm.90c.09001
Maria J. Antonelli
Assistant Professor of Medicine, Department of Medicine, Division of Rheumatology, Case Western Reserve University, MetroHealth Medical Center, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irving Kushner
Emeritus Professor of Medicine, Department of Medicine, Division of Rheumatology, Case Western Reserve University, MetroHealth Medical Center, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Murray Epstein
Emeritus Professor of Medicine, Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Miami, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

To the Editor: In previous publications, we presented evidence that 25-dehydroxyvitamin D (25[OH]D) in serum behaves as a negative acute-phase reactant, ie, that its concentration decreases in the presence of inflammatory states.1,2 Low levels may thus reflect low vitamin D stores or inflammation, complicating the clinical interpretation of test results.

We have recently become aware of the mechanism underlying this phenomenon: less than 1% of circulating 25(OH)D exists in unbound form, and the majority is tightly bound to vitamin D binding protein, while 10% to 15% is bound to albumin. Both are negative acute-phase proteins.3–5 As the serum concentrations of these proteins decrease, so does that of 25(OH)D. Similarly, the positive acute-phase behavior of copper is explained by the fact that it is bound to ceruloplasmin, a positive acute-phase protein.6

  • Copyright © 2023 The Cleveland Clinic Foundation. All Rights Reserved.

REFERENCES

  1. ↵
    1. Antonelli M,
    2. Kushner I
    . Low serum levels of 25-hydroxyvitamin D accompany severe COVID-19 because it is a negative acute phase reactant. Am J Med Sci 2021; 362(3):333–335. doi:10.1016/j.amjms.2021.06.005
    OpenUrlCrossRef
  2. ↵
    1. Antonelli MJ,
    2. Kushner I,
    3. Epstein M
    . The constellation of vitamin D, the acute-phase response, and inflammation. Cleve Clin J Med 2023; 90(2):85–89. doi:10.3949/ccjm.90a.22048
    OpenUrlFREE Full Text
  3. ↵
    1. Yousefzadeh P,
    2. Shapses SA,
    3. Wang X
    . Vitamin D binding protein impact on 25-hydroxyvitamin D levels under different physiologic and pathologic conditions. Int J Endocrinol 2014; 2014:981581. doi:10.1155/2014/981581
    OpenUrlCrossRef
    1. Dahl B,
    2. Schiødt FV,
    3. Gehrchen PM,
    4. Ramlau J,
    5. Kiaer T,
    6. Ott P
    . Gc-globulin is an acute phase reactant and an indicator of muscle injury after spinal surgery. Inflamm Res 2001; 50(1):39–43. doi:10.1007/s000110050722
    OpenUrlCrossRefPubMed
  4. ↵
    1. Feingold KR,
    2. Anawalt B,
    3. Blackman MR, et al.
    1. Liberman U,
    2. Bikle DD
    . Disorders in the action of vitamin D. In: Feingold KR, Anawalt B, Blackman MR, et al., eds. Endotext. South Dartmouth, MA: MDText.com, Inc.; 2023.
  5. ↵
    1. Sattar N,
    2. Scott HR,
    3. McMillan DC,
    4. Talwar D,
    5. O’Reilly DS,
    6. Fell GS
    . Acute-phase reactants and plasma trace element concentrations in non-small cell lung cancer patients and controls. Nutr Cancer 1997; 28(3):308–312. doi:10.1080/01635589709514592
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 90 (9)
Cleveland Clinic Journal of Medicine
Vol. 90, Issue 9
1 Sep 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Why 25-dehydroxyvitamin D is a negative acute-phase reactant
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Why 25-dehydroxyvitamin D is a negative acute-phase reactant
Maria J. Antonelli, Irving Kushner, Murray Epstein
Cleveland Clinic Journal of Medicine Sep 2023, 90 (9) 535; DOI: 10.3949/ccjm.90c.09001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Why 25-dehydroxyvitamin D is a negative acute-phase reactant
Maria J. Antonelli, Irving Kushner, Murray Epstein
Cleveland Clinic Journal of Medicine Sep 2023, 90 (9) 535; DOI: 10.3949/ccjm.90c.09001
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Primary adrenal insufficiency in adults
  • Late complications after allogeneic hematopoietic cell transplant
Show more Letter to the Editor

Similar Articles

Subjects

  • Endocrinology
  • Rheumatology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire